S-phase entry of oligodendrocyte lineage cells is associated with increased levels of p21Cip1

Journal of Neuroscience Research

Volumn 80, Issue 3, 2005, Pages 360-368

  Bansal, Rashmi ^a,c   Marin Husstege, Mireya ^b   Bryant, Melissa ^a   Casaccia Bonnefil, Patrizia ^b  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^c UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Cell cycle; FGF; Glia; Myelin; Proliferation

Indexed keywords

BROXURIDINE; CYCLIN D1; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN E; CYCLINE; FIBROBLAST GROWTH FACTOR 2; GROWTH FACTOR; PROTEIN P18; PROTEIN P18INK; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CYCLE S PHASE; CELL LINEAGE; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; COMPLEX FORMATION; CONTROLLED STUDY; MYELINATION; NERVE CELL DIFFERENTIATION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; REGULATORY MECHANISM; STEM CELL;

ANIMALS; ANIMALS, NEWBORN; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL LINEAGE; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM; CYCLIN D1; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE INHIBITOR P18; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASES; FIBROBLAST GROWTH FACTOR 2; MACROMOLECULAR SUBSTANCES; NERVE REGENERATION; OLIGODENDROGLIA; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS; RATS; RETINOBLASTOMA PROTEIN; S PHASE; STEM CELLS; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 20344386263     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.20454     Document Type: Article

References (61)

1. Bansal R. 2002. Fibroblast growth factors and their receptors in oligodendrocyte development: implications for demyelination and remyelination. Dev Neurosci 24:35-46.
2. Bansal R, Pfeiffer SE. 1992. Novel stage in the oligodendrocyte lineage defined by reactivity of progenitors with R-mAb prior to O1 antigalactocerebroside. J Neurosci Res 32:309-316.
3. Bansal R, Pfeiffer SE. 1994. Inhibition of protein and lipid sulfation in oligodendrocytes blocks biological responses to FGF-2 and retards cytoarchitectural maturation, but not developmental lineage progression. Dev Biol 162:511-524.
4. Bansal R, Pfeiffer SE. 1997. FGF-2 converts mature oligodendrocytes to a novel phenotype. J Neurosci Res 50:215-228.
5. Bansal R, Kumar M, Murray K, Morrison RS, Pfeiffer SE. 1996. Regulation of FGF receptors in the oligodendrocyte lineage. Mol Cell Neurosci 7:263-275.
6. Bansal R, Lakhina V, Remedios R, Tole S. 2003a. Expression of FGF receptors 1, 2, 3 in the embryonic and postnatal mouse brain compared with Pdgfr alpha, Olig2 and Plp/dm20: implications for oligodendrocyte development. Dev Neurosci 25:83-95.
7. Bansal R, Magge S, Winkler S. 2003b. Specific inhibitor of FGF receptor signaling: FGF-2-mediated effects on proliferation, differentiation, and MAPK activation are inhibited by PD173074 in oligodendrocyte-lineage cells. J Neurosci Res 74:486-493.
8. Bogler O, Wren D, Barnett SC, Land H, Noble M. 1990. Cooperation between two growth factors promotes extended self-renewal and inhibits differentiation of oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells. Proc Natl Acad Sci U S A 87:6368-6372.
9. Casaccia-Bonnefil P, Liu A. 2003. Relationship between cell cycle molecules and onset of oligodendrocyte differentiation. J Neurosci Res 72:1-11.
10. Casaccia-Bonnefil P, Carter BD, Dobrowsky RT, Chao MV. 1996. Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature 383:716-719.
11. Casaccia-Bonnefil P, Tikoo R, Kiyokawa H, Friedrich V Jr, Chao MV, Koff A. 1997. Oligodendrocyte precursor differentiation is perturbed in the absence of the cyclin-dependent kinase inhibitor p27Kip1. Genes Dev 11:2335-2346.
12. Casaccia-Bonnefil P, Hardy RJ, Teng KK, Levine JM, Koff A, Chao MV. 1999. Loss of p27Kip1 function results in increased proliferative capacity of oligodendrocyte progenitors but unaltered timing of differentiation. Development 126:4027-4037.
13. Cheng M, Olivier P, Diehl JA, Fero M, Roussel MF, Roberts JM, Sherr CJ. 1999. The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J 18:1571-1583.
14. Durand B, Gao FB, Raff M. 1997. Accumulation of the cyclin-dependent kinase inhibitor p27/Kip1 and the timing of oligodendrocyte differentiation. EMBO J 16:306-317.
15. Durand B, Fero ML, Roberts JM, Raff MC. 1998. p27Kip1 alters the response of cells to mitogen and is part of a cell-intrinsic timer that arrests the cell cycle and initiates differentiation. Curr Biol 8:431-440.
16. Ford-Perriss M, Abud H, Murphy M. 2001. Fibroblast growth factors in the developing central nervous system. Clin Exp Pharmacol Physiol 28:493-503.
17. Fredericks TJ, Wood TL. 2004. IGF-I and FGF-2 coordinately enhance cyclin D1 and cyclin E-cdk2 association and activity to promote G1 progression in oligodendrocyte progenitor cells. Mol Cell Neurosci 25:480-492.
18. Fressinaud C, Laeng P, Labourdette G, Durand J, Vallat JM. 1993. The proliferation of mature oligodendrocytes in vitro is stimulated by basic fibroblast growth factor and inhibited by oligodendrocyte-type 2 astrocyte precursors. Dev Biol 158:317-329.
19. - oligodendrocyte progenitors. Dev Biol 159:618-630.
20. Ghiani C, Gallo V. 2001. Inhibition of cyclin E-cyclin-dependent kinase 2 complex formation and activity is associated with cell cycle arrest and withdrawal in oligodendrocyte progenitor cells. J Neurosci 21:1274-1282.
21. Ghiani CA, Eisen AM, Yuan X, DePinho RA, McBain CJ, Gallo V. 1999a. Neurotransmitter receptor activation triggers p27(Kip1) and p21(CIP1) accumulation and G1 cell cycle arrest in oligodendrocyte progenitors. Development 126:1077-1090.
22. + channels and membrane depolarization regulate accumulation of the cyclin-dependent kinase inhibitors p27(Kip1) and p21(CIP1) in glial progenitor cells. J Neurosci 19:5380-5392.
23. Goldman JE, Zerlin M, Newman S, Zhang L, Gensert J. 1997. Fate determination and migration of progenitors in the postnatal mammalian CNS. Dev Neurosci 19:42-48.
24. Grinspan JB, Stern JL, Franceschini B, Pleasure D. 1993. Trophic effects of basic fibroblast growth factor (bFGF) on differentiated oligodendroglia: a mechanism for regeneration of the oligodendroglial lineage. J Neurosci Res 36:672-680.
25. Guan KL, Jenkins CW, Li Y, O'Keefe CL, Noh S, Wu X, Zariwala M, Matera AG, Xiong Y. 1996. Isolation and characterization of p19INK4d, a p16-related inhibitor specific to CDK6 and CDK4. Mol Biol Cell 7:57-70.
26. Hardy R, Reynolds R. 1991. Proliferation and differentiation potential of rat forebrain oligodendroglial progenitors both in vitro and in vivo. Development 111:1061-1080.
27. Jung JM, Bruner JM, Ruan S, Langford LA, Kyritsis AP, Kobayashi T, Levin VA, Zhang W. 1995. Increased levels of p21WAF1/Cip1 in human brain tumors. Oncogene 11:2021-2028.
28. Kato A, Ota S, Bamba H, Wong RM, Ohmura E, Imai Y, Matsuzaki F. 1998. Regulation of cyclin D-dependent kinase activity in rat liver regeneration. Biochem Biophys Res Commun 245:70-74.
29. LaBaer J, Garrett MD, Stevenson LF, Slingerland JM, Sandhu C, Chou HS, Fattaey A, Harlow E. 1997. New functional activities for the p21 family of CDK inhibitors. Genes Dev 11:847-862.
30. Mayer M, Bogler O, Noble M. 1993. The inhibition of oligodendrocytic differentiation of O-2A progenitors caused by basic fibroblast growth factor is overridden by astrocytes. Glia 8:12-19.
31. McKinnon RD, Matsui T, Dubois-Dalcq M, Aaronson SA. 1990. FGF modulates the PDGF-driven pathway of oligodendrocyte development. Neuron 5:603-614.
32. McMorris FA, McKinnon RD. 1996. Regulation of oligodendrocyte development and CNS myelination by growth factors: prospects for therapy of demyelinating disease. Brain Pathol 6:313-329.
33. Michieli P, Chedid M, Lin D, Pierce JH, Mercer WE, Givol D. 1994. Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res 54:3391-3395.
34. Miller RH. 1996. Oligodendrocyte origins. Trends Neurosci 19:92-96.
35. Milner R, Anderson HJ, Rippon RF, McKay JS, Franklin RJ, Marchionni MA, Reynolds R, Ffrench-Constant C. 1997. Contrasting effects of mitogenic growth factors on oligodendrocyte precursor cell migration. Glia 19:85-90.
36. Norton WT. 1996. Do oligodendrocytes divide? Neurochem Res 21:495-503.
37. Oh LY, Denninger A, Colvin JS, Vyas A, Tole S, Ornitz DM, Bansal R. 2003. Fibroblast growth factor receptor 3 signaling regulates the onset of oligodendrocyte terminal differentiation. J Neurosci 23:883-894.
38. Ono Y, Tamiya T, Ichikawa T, Matsumoto K, Furuta T, Ohmoto T, Akiyama K, Seki S, Ueki K, Louis DN. 1997 Accumulation of wild-type p53 in astrocytomas is associated with increased p21 expression. Acta Neuropathol 94:21-27.
39. Ornitz DM, Itoh N. 2001. Fibroblast growth factors. Genome Biol 2:3005.
40. Ortega S, Malumbres M, Barbacid M. 2002. Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim Biophys Acta 1602:73-87.
41. Osterhout DJ, Ebner S, Xu J, Ornitz DM, Zazanis GA, McKinnon RD. 1997. Transplanted oligodendrocyte progenitor cells expressing a dominant-negative FGF receptor transgene fail to migrate in vivo. J Neurosci 17:9122-9132.
42. Parry D, Bates S, Mann DJ, Peters G. 1995. Lack of cyclin D-Cdk complexes in Rb-negative cells correlates with high levels of p16INK4/MTS1 tumour suppressor gene product. EMBO J 14:503-511.
43. Parry D, Mahony D, Wills K, Lees E. 1999. Cyclin D-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors. Mol Cell Biol 19:1775-1783.
44. Pfeiffer SE, Warrington AE, Bansal R. 1993. The oligodendrocyte and its many cellular processes. Trends Cell Biol 3:191-197.
45. Polyak K, Lee MH, Erdjument-Bromage H, Koff A, Roberts JM, Tempst P, Massague J. 1994. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78:59-66.
46. Ruas M, Peters G. 1998. The p16INK4a/CDKN2A tumor suppressor and its relatives. Biochim Biophys Acta 1378:F115-F177.
47. Russo AA, Jeffrey PD, Patten AK, Massague J, Pavletich NP. 1996. Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex. Nature 382:325-331.
48. Sherr CJ. 1994. G1 phase progression: cycling on cue. Cell 79:551-555.
49. Sherr CJ, Roberts JM. 1999. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13:1501-1512.
50. Szebenyi G, Fallon JF. 1999. Fibroblast growth factors as multifunctional signaling factors. Int Rev Cytol 185:45-106.
51. Tang XM, Strocchi P, Cambi F. 1998. Changes in the activity of cdk2 and cdk5 accompany differentiation of rat primary oligodendrocytes. J Cell Biochem 68:128-137.
52. Tikoo R, Osterhout DJ, Casaccia-Bonnefil P, Seth P, Koff A, Chao MV. 1998. Ectopic expression of p27Kip1 in oligodendrocyte progenitor cells results in cell-cycle growth arrest. J Neurobiol 36:431-440.
53. Tokumoto YM, Tang DG, Raff MC. 2001. Two molecularly distinct intracellular pathways to oligodendrocyte differentiation: role of a p53 family protein. EMBO J 20:5261-5268.
54. Toyoshima H, Hunter T. 1994. p27, A novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78:67-74.
55. Vick RS, DeVries GH. 1992. Mitotic potential of adult rat oligodendrocytes in culture. J Neurosci Res 33:68-74.
56. Wang H, Rubin M, Fenig E, DeBlasio A, Mendelsohn J, Yahalom J, Wieder R. 1997. Basic fibroblast growth factor causes growth arrest in MCF-7 human breast cancer cells while inducing both mitogenic and inhibitory G1 events. Cancer Res 57:1750-1757.
57. + oligodendrocytes in postnatal rat cerebellum: analysis in unfixed tissue slices using anti-glycolipid antibodies. J Neurosci Res 33:338-353.
58. Wood PM, Bunge RP. 1991. The origin of remyelinating cells in the adult central nervous system: the role of the mature oligodendrocyte. Glia 4:225-232.
59. Woodruff RH, Tekki-Kessaris N, Stiles CD, Rowitch DH, Richardson WD. 2001. Oligodendrocyte development in the spinal cord and telencephalon: common themes and new perspectives. Int J Dev Neurosci 19:379-385.
60. Zezula J, Casaccia-Bonnefil P, Ezhevsky SA, Osterhout DJ, Levine JM, Dowdy SF, Chao MV, Koff A. 2001. p21cip1 Is required for the differentiation of oligodendrocytes independently of cell cycle withdrawal. EMBO Rep 2:27-34.
61. Zhang HS, Gavin M, Dahiya A, Postigo AA, Ma D, Luo RX, Harbour JW, Dean DC. 2000. Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF. Cell 101:79-89.